Word

Status

Pending

Status Code

630

Status Date

Wednesday, February 21, 2024

Serial Number

98413936

Mark Type

0000

Filing Date

Wednesday, February 21, 2024

Trademark Owner History

Gordian Biotechnology

Classifications

5 Pharmaceutical preparations, biological preparations, and cell- and gene-based therapy products to prevent and treat age-related cardiovascular disease, neurodegenerative disease, musculoskeletal disease, pulmonary disease, metabolic disease, diseases of the liver, macular degeneration and other ocular diseases, kidney disease, and cancer; pharmaceutical preparations, biological preparations, and cell- and gene-based therapy products to prevent and treat cardiovascular disease, neurodegenerative disease, musculoskeletal disease, pulmonary disease, metabolic disease, diseases of the liver, macular degeneration and other ocular diseases, kidney disease, and cancer

44 Providing medical information on aging and complex multigenic diseases

42 Pharmaceutical and biological drug research and development services; research and development of pharmaceutical and biotechnology fields, namely, cell- and gene-based therapy research and development services; providing information about medical and scientific research on aging and complex multigenic diseases; providing information about medical and scientific research, namely, providing information on pharmaceutical drug, biological drug, and cell- and gene-based therapy research and development; providing scientific information on computational biology, machine learning, and bioinformatics

The mark consists of the wording "Gordian" with a partial "a" and a diagonal edge extending from the top of the letter "d" to the bottom of the letter "a".
Color is not claimed as a feature of the mark.

Trademark Events

Feb 21, 2024

New Application Entered